Medical weight loss: building a body that loses weight more easily
Value sets
Delivered once every 45 days.
From the second order onwards the price is 20% off the one-time purchase price, and the plan cannot be cancelled until the second delivery has been received.
Popular ranges
[Cyspera: an official-level range at some of the lowest prices]
From the main lines to limited items, every kind you might want is here, at prices set below the official ones, so you can get what you need quickly and at low cost.
A weight plan matched to you
[ Mounjaro®, a GLP-1/GIP agonist / Zepbound®, a medicine for obesity ]
A new way to build your body, without going without
Zepbound and Mounjaro areThe GLP-1/GIP receptor agonists attracting attention right now.They support the action of hormones already in the body (GLP-1 and GIP),They help settle the appetite naturally and raise the metabolism.
Rather than going without or restricting yourself too far, this is a new kind of weight support that puts the body’s own rhythm in healthy order.
Easy to keep up,
Care at your own pace, once a week
One self-injection a weekis enough. With an easy-to-use pen device, you can keep going at your own pace with a doctor’s support.
A way of working that fits into busy days: not a diet you push at every day, but a habit of putting your body in order once a week.
Approved by the MHLW and the FDA
Quality you can rely on, grounded in evidence
Zepbound is a medicine for obesityapproved by the Ministry of Health, Labour and Welfare in Japan and by the FDA in the United States.
Mounjaro is a medicine for type 2 diabetesapproved in both countries, with efficacy and safety confirmed scientifically in clinical trials.
From consultation to receiving your medication
Everything completed online
Online consultation lets you speak to a doctor from anywhere in Japan. Consultation, prescription, payment and delivery are all completed online, so there is no travelling to appointments or waiting at a pharmacy, and even busy people can keep it up comfortably.
Backed by clinical data
What GLP-1/GIP weight management does
Efficacy and safety have been established in international clinical trials carried out in more than 40 countries. The main trials reported average weight loss of 15 to 20% and improved blood sugar control, results exceeding those of earlier GLP-1 medicines.
Trusted in more than 150 countries,
A global pharmaceutical brand
Developed by Eli Lilly, a global pharmaceutical company with more than a century of history. It is used in medical institutions around the world, with efficacy and safety confirmed in clinical trials. Because it rests on scientific evidence, it is trusted by doctors and specialists.
For first-time users
